4Nonstandardabbreviations:
IndexIngTerms: liver transplantation/isoelectric focusing/transplant rejection/I iver enzymes
There are no artificial support systems to replace liver function in patients with end-stage liver disease; the only alternative today is liver transplantation. 
Rejection and infections

4Nonstandardabbreviations:
OLT, orthotopic liver transplantation; CMV, cytomegalovirus; LVI, liver-function tests; ALP, a!-kalinephosphatase; IEF, isoelectric focusing; PAGE, polyacrylamide gel electrophoresis; HMM, high molecular mass; OSU, Ohio State University; AST, aspartate amunotransferase; ALT, alanine aminotransferase; GGT, y-glutamyltransferase; TBIL, total bilirubin; and DBIL, direct bilirubin.
Received 
MaterIals and Methods
Patients and Diagnosis
We included in the study 65 patients, 33 males and 32 females, ages 14-65 years, who received liver allografts AB CD E The application template was placed 1 cm toward the cathodal side from the center of the gel. If any HMM ALP was present in the sample, this template placement ensured that the canalicular and hepatocyte bands were not obscured by the nonmigrating HMM smudge that remained at the point of application.
When 11MM ALP was present, bands 6-10 were obscured. We applied 15 L of serum to each well and allowed it to soak into the gel. The electrophoresis unit was cooledto 18#{176}C during electrophoresis.
The voltage limitwas set to 1100 V, and the gel was electrophoresed (20) .
Ten (15%) of the patients died, and 47 (72%) had a complicated post-OLT course. 
#{149} Values calculatedfrom reference ranges established by Griffithsand Black(11).
OLT. Converting 11MM to bands IA and lB (Fig. 1) and interpreting the amount of 11MM ALP present from these data is problematic. In studies with Triton X-100, we observed bands more acidic than band 1 and additional fractions between bands 1 and 2 that were very different from the other ALP bands. Triton X-100 treatment also reduced the total ALP activity by -30%; hence we recommend against using Triton X-100.
Two pooled serum controls, one containing serum from normal females and one from normal males, were applied to each gel to estimate the between-run variability; each pool was assayed 12 times. For bands 1 and 2 from the pooled female serum we found means (SD) of 11.4 (3.5) U/L and 18.3 (4.5) TilL, respectively; for bands 1 and 2 for the pooled male serum, the means were 6.5 (2.2) U/L and 14.7 (4.3) UIL, respectively.
Results and Discussion Post-OLT Analyte Ranges for Stable Patients
Ranges were determined for ALP bands 1 and 2 and HMM ALP as well as totalALP, GGT, AST, TBIL, and DBIL in stable post-OLT patients defined as those having no complication, i.e., freeof biopsy-diagnosed rejection, CMV infection, and biliary tract complications. The test values from these complication-free periods were organized accordingto three post-OLT time intervals: 60-180 days, 181-365 days, and >365 days. The analyte ranges of the stable patients along with reference values from controls are shown in Table 2 .
Routine Laboratory Data in Stable Post-OLT Patients
The majority (67% at 60-180 days, 67% at 181-365 days, and 74% at >365 days) of the post-OLT total ALP values were within the normal range of 36-126 U/L. Also, for these OLT cases, the mean ALP decreased during the 365-day period. The mean GGT values from the three post-OLT time groups were always higher than the normal range. There was a consistent increase of the mean AST beginning during the 60-180-day period through Statistical differences for the various tests between the patients with a stable outcome and those with complications are shown in Table 3 . In 35% of the patients, the increases in the ALP fractions occurred as early as 3-10 days before the diagnosis of a post-OLT complication. During other episodes, the increases were present at or after the diagnosis of complications.
Several patients exhibited both increased LFT and ALP isoforms, but there was no coincident biopsy or associated diagnosis; thus, post-OLT complications may have been missed.
Rejection group. All patients in this group had rejection episodes at 60-180 and 181-365 days post-OLT ( Fig. 2 and Table 3 ). The proportions of patients having abnormal routine LFT and ALP isoforms are shown in Table 2 . Reference ranges (and means) from serum of controls and stable post-OLT patients. Table 3 . ALP and GGT were increased in nearly all patients (P <0.01 and P <0.05, respectively, vs stable patients), and band 1 was increasedin all (P <0.01 vs Valueson the x-axis were chosen to expand the results inthe lower ranges. tion episodes occurring at 60-180 days and 181-365 days post-OLT are not the same (Table 3 ). The mean values for the later time are all higher, suggesting that late rejection is a more severe process.
Rejection and CMV. Compared with the stable group, these patients had the highest mean values and statistically significant differences (Table 3) for all tests, suggesting that they had the most serious biochemical derangements, a finding consistent with the clinical picture: These individuals tended to be much sicker. The high activity and concentrations of 11MM ALP in these cases suggest a more severe cholestatic process than in the other groups.
Cholangitis and biliwy complications.
On the basis of the data in Table 3 , these patients are indistinguishable from those with a diagnosis of rejection. Bands 1 and 2 show good sensitivity (P <0.001 vs the stable group), suggesting both canalicular and hepatocyte involvement in the disease process.
When the data from all the patients are considered, the ALP isoforms and 11MM ALP can indicate a post-OLT complication, but there does not appear to be a "typical"ALP isoform profile for a given type of post-OLT complication.
The ALP fractions increased before the LF1 in a number of cases, which could lead to an earlier liver biopsy, diagnosis, and treatment. 
